Today's Hours: 8:00am - 10:00pm
Lane Medical Library

Search

Filter Results

Did You Mean:

Search Results

Sort by
relevance
  • Book
    Gianfranco Butera, John Cheatham, Carlos A.C. Pedra, Dietmar Schranz, Gerald Tulzer, editors.
    Contents:
    Part I-Introductory aspects in fetal procedures/Ethical aspects of fetal heart interventions
    Tools in fetal heart procedures
    Role of Multicenter Registries to Assess Outcomes of Fetal Interventions
    Role of Counseling in Fetal Congenital Heart Diseases
    Part II
    Aortic valve disease/Fetal Anatomy: the aortic valve in the fetal aortic valve diseases
    Fetal aortic stenosis
    natural history and echocardiographic evaluation
    Fetal Aortic Valvuloplasty (FAV)
    Fetal aortic valvuloplasty: state of art
    Part III
    Pulmonary valve disease/Fetal anatomy: the pulmonary valve in the fetal pulmonary valve disease
    Fetal pulmonary valvuloplasty: Natural history and echocardiographic evaluation of Critical Pulmonary stenosis/ Pulmonary atresia with intact ventricular septum
    Indications for fetal pulmonary valvuloplasty
    Center experience and step-by-step approach for fetal pulmonary valvuloplasty
    Pulmonary valvuloplasty: Fetal, neonatal and follow up outcomes
    Literature on fetal therapy after pulmonary valvuloplasty
    Future perspectives on fetal pulmonary valvuloplasty
    Part IV
    Procedures on the interatrial septum/The embryology of the interatrial septum
    Fetal anatomy: the inter atrial septum in the fetus with congenital heart disease
    Literature on fetal therapy on interatrial septum
    Procedures on the Atrial Septum
    Part V
    Fetal procedures: Other treatments and approaches/Perspectives On Fetal Pacing
    Alternative vascular access in fetus
    Part VII
    Introductory aspects in hybrid procedures/Physician's Perspective
    Parents' Perspective on the Hybrid Approach
    The Hybrid Catheterization Laboratory
    Part VIII
    Hypoplastic Left Heart Syndrome (HLHS)/Hypoplastic left heart syndrome natural and surgical history
    The engineering perspective
    General principles of the hybrid approach in Hypoplastic Left Heart Syndrome
    Hypoplastic Left Heart Syndrome: The Giessen approach
    history, technique and results
    Hybrid Approach: The Columbus way
    The Brazilian Hybrid Approach for Hypoplastic Left Heart Syndrome
    Canadian approach to hybrid HLHS.-Prolonged Right Ventricle To Left Ventricle Support (Hybrid Or Surgical) To Delay Decision Making In Borderline Left Ventricles
    The Anatomical or Functional Borderline Left Ventricle and Strategies for Staged Rehabilitation
    Part IX
    Pulmonary Arteries/Pulmonary arteries: surgical point of view
    Exit Angiography
    Role of 3-Dimensional Rotational Angiography in Imaging the Pulmonary Arteries
    Hybrid Approach to Pulmonary Artery Stenosis
    Literature and Results
    Part X
    Ventricular Septal Defect/Hybrid Closure of Muscular Ventricular Septal Defects: anatomy, clinical scenarios and techniques
    Hybrid Muscular Ventricular Septal Defect Closure: Literature And Results
    Perimembranous VSD
    Part XI
    Other Hybrid Procedures/Hybrid Atrial Septal Defect Closure
    Treatment of RV Outflow Tract Dysfunction: New Valve Technologies
    Mitral Valve Replacement with Melody Valve Prosthesis
    A Hybrid Approach to Aortic Stent Implantation
    Other hybrid treatments: tetralogy of Fallot
    Other hybrid treatments: RV-to-PA hybrid conduit
    Hybrid VSD creation or enlargement.
    Digital Access Springer 2016
  • Article
    Mühlpfordt H, Schottelius J.
    Tropenmed Parasitol. 1977 Mar;28(1):1-7.
    Protectin from the sponge Aaptos papillata (Keller) was used in the characterization of five strains of T. cruzi (Venezuela, Guatemala, Y. Brasilien, Peru, Wien) and six T. cruzi like strains (Triatoma, Maryland, ITMAP 943, FH4, FH5, LN). Based upon their membrane receptors, these T. cruzi and T. cruzi like isolates could be differentiated from rangeli (Venezuela Strain) and T. conorhini (Hawai Strain) by agglutination reaction to the proctectin. Furthermore, after pronase treatment T.rangeli could also be distinguished from T. conorhini by agglutination test with A. papillata protectin and also Soja hispida lectin. It is not possible to differentiate the T. cruzi complex with S. hispida lectin, because it did not agglutinate T. cruzi (Vienna Strain) and T. cruzi like (Maryland Strain). However, after treating this human pathogenic strain with pronase the pseudocrypt antigen of the first order is made available to the S. hispida lecting thereby producing agglutination. The T. cruzi like strain however did not agglutinate with this treatment. On the other hand, while T. rangeli did not agglutinate even after pronase treatment, T. conorhini showed the agglutination reaction. This observed reaction is explained by the availability of the pseudocrypt antigens of the first order after pronase treatment.
    Digital Access Access Options